Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

540
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
540
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

809
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
809
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

995
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
995
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

554
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
554
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

644
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
644
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

496
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
496

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short- and long-term outcomes of minimally invasive total mesorectal excision in obese versus nonobese patients with rectal cancer: a propensity score matched study.

Techniques in coloproctology·2026
Same author

Clinical Features Associated With Outcomes in Lung Cancer Patients Treated With Denosumab.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Comparison of short- and long-term outcomes among laparoscopic, robotic-assisted, and transanal total mesorectal excision procedures in patients with rectal cancer: a propensity score-matching analysis.

Techniques in coloproctology·2025
Same author

An unusual cause of dyspnoea.

BMJ case reports·2025
Same author

Early surgical intervention for extensive nontuberculous mycobacterial pulmonary disease.

IJTLD open·2025
Same author

Re: Increased nuchal translucency thickness and normal chromosomal microarray.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same journal

Response to letter from Mr. Yudai Kaneda entitled "Patient Preference and Generalisability in a Trial of Cheek Acupuncture for Stress Urinary Incontinence" (QJM-2026-999).

QJM : monthly journal of the Association of Physicians·2026
Same journal

Trends in mortality of people on dialysis in England and Wales over the last 15 years.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Familial pulmonary fibrosis due to pathogenic TERT variant presenting with a UIP-PPFE phenotype.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Corkscrew Oesophagus Due to Distal Oesophageal Spasm.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Correction to: Integrated care management for patients following acute stroke: a systematic review.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Methodological concerns regarding blinding and long term efficacy of fire needle therapy for plaque psoriasis.

QJM : monthly journal of the Association of Physicians·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Intranasal Administration of CNS Therapeutics to Awake Mice
07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

Published on: April 8, 2013

61.3K

Dipeptidyl peptidase-4 inhibitor treatment could decrease chronic rhinosinusitis in diabetic patients.

S-Y Li1, H-H Chen2,3,4, C-C Lai5

  • 1From the Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Nanhsiau Street, Changhua, Taiwan.

QJM : Monthly Journal of the Association of Physicians
|October 5, 2019
PubMed
Summary
This summary is machine-generated.

Dipeptidyl peptidase-4 inhibitor (DPP4i) treatment may reduce the risk of chronic rhinosinusitis (CRS) in diabetic patients. This finding suggests a potential benefit of DPP4i for managing CRS in this population.

More Related Videos

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.2K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

2.2K

Related Experiment Videos

Last Updated: Jan 6, 2026

Intranasal Administration of CNS Therapeutics to Awake Mice
07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

Published on: April 8, 2013

61.3K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.2K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

2.2K

Area of Science:

  • Endocrinology
  • Immunology
  • Otolaryngology

Background:

  • Diabetes mellitus is a complex condition associated with various complications.
  • Chronic rhinosinusitis (CRS) is a prevalent inflammatory condition affecting the upper airways.
  • The interplay between diabetes and CRS risk warrants further investigation.

Purpose of the Study:

  • To investigate the association between dipeptidyl peptidase-4 inhibitor (DPP4i) use and the incidence of chronic rhinosinusitis (CRS) among diabetic patients.
  • To evaluate whether DPP4i treatment influences CRS risk in a Taiwanese diabetic population.

Main Methods:

  • A population-based, matched cohort study utilizing the Longitudinal Health Insurance Database.
  • Statistical analyses included Chi-square and Wilcoxon rank-sum tests for variable associations.
  • Kaplan-Meier method with log-rank test assessed CRS risk in DPP4i users versus non-users.

Main Results:

  • The study included 6198 diabetic patients.
  • DPP4i users exhibited a significantly lower risk of developing CRS.
  • Reduced CRS risk was observed in women, patients with higher Diabetes Complications Severity Index scores, those with comorbidities, and with higher cumulative DPP4i dosage.

Conclusions:

  • DPP4 inhibitor treatment is associated with a decreased risk of chronic rhinosinusitis in diabetic patients.
  • These findings suggest a potential protective effect of DPP4i against CRS development in this population.
  • Further research may explore the mechanisms underlying this observed association.